BROOKS LABORATORIES LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
21 Aug 2022
Update under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements, 2015) regarding approval for Meropenem Injection 500mg per vial and 1gram per vial (the product) from the United States Food & Drug Administration (USFDA)
Source:
BSE India